{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:40:38Z","timestamp":1784299238425,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>We describe 4 cases of cutaneous leishmaniasis in children in Australia. Treatment is challenging given lack of firm guidelines and limited access to conventional modalities used in endemic countries. Topical paromomycin or oral fluconazole were effective outpatient-based first-line treatments, however, topical paromomycin use was limited by expense to import or compound locally.<\/jats:p>","DOI":"10.1097\/inf.0000000000003445","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T12:38:36Z","timestamp":1640867916000},"page":"e177-e181","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of Cutaneous Leishmaniasis in a Nonendemic Country: A Case Series of Children in Australia"],"prefix":"10.1097","volume":"41","author":[{"given":"Nicholas","family":"Hill","sequence":"first","affiliation":[{"name":"Infection Management and Prevention Service, Queensland Children\u2019s Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Irwin","sequence":"additional","affiliation":[{"name":"Infection Management and Prevention Service, Queensland Children\u2019s Hospital, Brisbane, Queensland, Australia"},{"name":"Faculty of Medicine, University of Queensland, Herston, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette","family":"Graham","sequence":"additional","affiliation":[{"name":"Infection Management and Prevention Service, Queensland Children\u2019s Hospital, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Wagga Wagga Base Hospital, New South Wales, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua R.","family":"Francis","sequence":"additional","affiliation":[{"name":"Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia"},{"name":"Department of Paediatrics, Royal Darwin Hospital, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerilee","family":"Wall","sequence":"additional","affiliation":[{"name":"Dermatology Department, Princess Alexandra Hospital, Brisbane, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Nourse","sequence":"additional","affiliation":[{"name":"Infection Management and Prevention Service, Queensland Children\u2019s Hospital, Brisbane, Queensland, Australia"},{"name":"Faculty of Medicine, University of Queensland, Herston, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,28]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-4632.2007.03154.x","article-title":"Clinical manifestations and classification of Old World cutaneous leishmaniasis.","volume":"46","author":"Akilov","year":"2007","journal-title":"Int J Dermatol"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/eri.10.19","article-title":"Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis.","volume":"8","author":"Goto","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clindermatol.2006.05.008","article-title":"Cutaneous leishmaniasis.","volume":"25","author":"Bailey","year":"2007","journal-title":"Clin Dermatol"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1708-8305.2008.00223.x","article-title":"Leishmaniasis, an emerging imported infection: report of 20 cases from Australia.","volume":"15","author":"Stark","year":"2008","journal-title":"J Travel Med"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1017\/S0950268809002313","article-title":"New reports of Australian cutaneous leishmaniasis in Northern Australian macropods.","volume":"137","author":"Dougall","year":"2009","journal-title":"Epidemiol Infect"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijpara.2004.03.001","article-title":"Cutaneous leishmaniasis in red kangaroos: isolation and characterisation of the causative organisms.","volume":"34","author":"Rose","year":"2004","journal-title":"Int J Parasitol"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"e0119212","DOI":"10.1371\/journal.pone.0119212","article-title":"Molecular epidemiology of imported cases of leishmaniasis in Australia from 2008 to 2014.","volume":"10","author":"Roberts","year":"2015","journal-title":"PLoS One"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/jpids\/piu021","article-title":"Systemic meglumine antimoniate in cutaneous leishmaniasis of children: clinical and laboratory complications.","volume":"4","author":"Layegh","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.2012.11-0682","article-title":"Leishmaniasis in the United States: treatment in 2012.","volume":"86","author":"Murray","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/510860","article-title":"Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate.","volume":"195","author":"Cruz","year":"2007","journal-title":"J Infect Dis"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species.","volume":"64","author":"Palacios","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"R14-20250615","first-page":"1","article-title":"Chemotherapy of leishmaniasis: present challenges.","author":"Uliana","year":"2017","journal-title":"Parasitology"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4269\/ajtmh.2010.10-0171","article-title":"Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis.","volume":"83","author":"Wortmann","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major.","volume":"346","author":"Alrajhi","year":"2002","journal-title":"N Engl J Med"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1745-6215-13-58","article-title":"Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis [published correction appears in Trials. 2017 Sep 1;18(1):408].","volume":"13","author":"L\u00f3pez","year":"2012","journal-title":"Trials"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1440-0960.2005.00146.x","article-title":"Cutaneous leishmaniasis in Afghani refugees.","volume":"46","author":"Storer","year":"2005","journal-title":"Australas J Dermatol"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/AAC.26.5.745","article-title":"Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals.","volume":"26","author":"El-On","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1371\/journal.pntd.0000381","article-title":"Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials.","volume":"3","author":"Kim","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","article-title":"Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.","volume":"368","author":"Ben Salah","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:03:22Z","timestamp":1750003402000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,28]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003445","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,28]]}}}